Ability Pharmaceuticals, S.L. announced that it will raise €2.46 million in a equity round of funding on December 28, 2020. The company singed a purchase agreement with, SciClone Pharmaceuticals, Inc. The transaction is expected to close between between 2020 and 2021, investing in €820,000 in 2020, and €1.63 in 2021.